Diagnostic Imaging and Cytopathology Testing in Tumor Detection
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (28 December 2023) | Viewed by 198
Special Issue Editor
Interests: prognostic markers; tumors; epithelial-mesenchymal transition; cancer stem cells; cancer biomarkers; immunohistochemistry; molecular oncology; tumor genetics; diagnosis
Special Issue Information
Dear Colleagues,
As one of the prevalent causes of death in the world, tumors are associated with highly variable clinical and biological scenarios. The early diagnosis of tumors and precision medicine can greatly enhance patient survival rates. Our aim is to optimize the clinical workflow by combining accurate diagnosis with appropriate treatment. Techniques such as diagnostic imaging and cytopathology testing provide reliable diagnostic and prognostic biomarkers for precise oncology. These technological advancements can significantly enhance the accuracy of disease diagnosis and provide guidance for appropriate tumor care and prognosis.
This Special Issue will provide a platform for researchers and practitioners to publish original research articles that address state-of-the-art and novel methodologies and applications for oncological image analysis.
Dr. Anna Seo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diagnostic imaging
- cytopathology testing
- tumor detection
- oncology
- cancer
- screening
- precision medicine
- prognostic markers
- cancer biomarkers
- immunohistochemistry
- molecular oncology
- tumor genetics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
